206 related articles for article (PubMed ID: 20529331)
1. Vaccination response to protein and carbohydrate antigens in patients with rheumatoid arthritis after rituximab treatment.
Rehnberg M; Brisslert M; Amu S; Zendjanchi K; Håwi G; Bokarewa MI
Arthritis Res Ther; 2010; 12(3):R111. PubMed ID: 20529331
[TBL] [Abstract][Full Text] [Related]
2. The cellular immune response to influenza vaccination is preserved in rheumatoid arthritis patients treated with rituximab.
Arad U; Tzadok S; Amir S; Mandelboim M; Mendelson E; Wigler I; Sarbagil-Maman H; Paran D; Caspi D; Elkayam O
Vaccine; 2011 Feb; 29(8):1643-8. PubMed ID: 21211590
[TBL] [Abstract][Full Text] [Related]
3. Rituximab impairs immunoglobulin (Ig)M and IgG (subclass) responses after influenza vaccination in rheumatoid arthritis patients.
Westra J; van Assen S; Wilting KR; Land J; Horst G; de Haan A; Bijl M
Clin Exp Immunol; 2014 Oct; 178(1):40-7. PubMed ID: 24889761
[TBL] [Abstract][Full Text] [Related]
4. Effect of methotrexate, anti-tumor necrosis factor α, and rituximab on the immune response to influenza and pneumococcal vaccines in patients with rheumatoid arthritis: a systematic review and meta-analysis.
Hua C; Barnetche T; Combe B; Morel J
Arthritis Care Res (Hoboken); 2014 Jul; 66(7):1016-26. PubMed ID: 24339395
[TBL] [Abstract][Full Text] [Related]
5. Humoral responses after influenza vaccination are severely reduced in patients with rheumatoid arthritis treated with rituximab.
van Assen S; Holvast A; Benne CA; Posthumus MD; van Leeuwen MA; Voskuyl AE; Blom M; Risselada AP; de Haan A; Westra J; Kallenberg CG; Bijl M
Arthritis Rheum; 2010 Jan; 62(1):75-81. PubMed ID: 20039396
[TBL] [Abstract][Full Text] [Related]
6. Rituximab and abatacept but not tocilizumab impair antibody response to pneumococcal conjugate vaccine in patients with rheumatoid arthritis.
Crnkic Kapetanovic M; Saxne T; Jönsson G; Truedsson L; Geborek P
Arthritis Res Ther; 2013 Oct; 15(5):R171. PubMed ID: 24286269
[TBL] [Abstract][Full Text] [Related]
7. B cell depletion may be more effective than switching to an alternative anti-tumor necrosis factor agent in rheumatoid arthritis patients with inadequate response to anti-tumor necrosis factor agents.
Finckh A; Ciurea A; Brulhart L; Kyburz D; Möller B; Dehler S; Revaz S; Dudler J; Gabay C;
Arthritis Rheum; 2007 May; 56(5):1417-23. PubMed ID: 17469098
[TBL] [Abstract][Full Text] [Related]
8. Antibody response to pneumococcal and influenza vaccination in patients with rheumatoid arthritis receiving abatacept.
Alten R; Bingham CO; Cohen SB; Curtis JR; Kelly S; Wong D; Genovese MC
BMC Musculoskelet Disord; 2016 May; 17():231. PubMed ID: 27229685
[TBL] [Abstract][Full Text] [Related]
9. Immunization responses in rheumatoid arthritis patients treated with rituximab: results from a controlled clinical trial.
Bingham CO; Looney RJ; Deodhar A; Halsey N; Greenwald M; Codding C; Trzaskoma B; Martin F; Agarwal S; Kelman A
Arthritis Rheum; 2010 Jan; 62(1):64-74. PubMed ID: 20039397
[TBL] [Abstract][Full Text] [Related]
10. A Systematic Review and Metaanalysis of Antirheumatic Drugs and Vaccine Immunogenicity in Rheumatoid Arthritis.
Subesinghe S; Bechman K; Rutherford AI; Goldblatt D; Galloway JB
J Rheumatol; 2018 Jun; 45(6):733-744. PubMed ID: 29545454
[TBL] [Abstract][Full Text] [Related]
11. Vaccine responses in patients with rheumatoid arthritis treated with certolizumab pegol: results from a single-blind randomized phase IV trial.
Kivitz AJ; Schechtman J; Texter M; Fichtner A; de Longueville M; Chartash EK
J Rheumatol; 2014 Apr; 41(4):648-57. PubMed ID: 24584918
[TBL] [Abstract][Full Text] [Related]
12. Rituximab or a second anti-tumor necrosis factor therapy for rheumatoid arthritis patients who have failed their first anti-tumor necrosis factor therapy? Comparative analysis from the British Society for Rheumatology Biologics Register.
Soliman MM; Hyrich KL; Lunt M; Watson KD; Symmons DP; Ashcroft DM;
Arthritis Care Res (Hoboken); 2012 Aug; 64(8):1108-15. PubMed ID: 22422731
[TBL] [Abstract][Full Text] [Related]
13. Vaccination against influenza in patients with rheumatoid arthritis: the effect of rituximab on the humoral response.
Oren S; Mandelboim M; Braun-Moscovici Y; Paran D; Ablin J; Litinsky I; Comaneshter D; Levartovsky D; Mendelson E; Azar R; Wigler I; Balbir-Gurman A; Caspi D; Elkayam O
Ann Rheum Dis; 2008 Jul; 67(7):937-41. PubMed ID: 17981914
[TBL] [Abstract][Full Text] [Related]
14. Immune response to influenza vaccine and pneumococcal polysaccharide vaccine under IL-6 signal inhibition therapy with tocilizumab.
Tsuru T; Terao K; Murakami M; Matsutani T; Suzaki M; Amamoto T; Nakashima H; Akiyama A; Nishimoto N
Mod Rheumatol; 2014 May; 24(3):511-6. PubMed ID: 24252023
[TBL] [Abstract][Full Text] [Related]
15. Baseline serum immunoglobulin levels in patients with rheumatoid arthritis: relationships with clinical parameters and with B-cell dynamics following rituximab.
de la Torre I; Leandro MJ; Edwards JC; Cambridge G
Clin Exp Rheumatol; 2012; 30(4):554-60. PubMed ID: 22510323
[TBL] [Abstract][Full Text] [Related]
16. Methotrexate reduces vaccine-specific immunoglobulin levels but not numbers of circulating antibody-producing B cells in rheumatoid arthritis after vaccination with a conjugate pneumococcal vaccine.
Kapetanovic MC; Nagel J; Nordström I; Saxne T; Geborek P; Rudin A
Vaccine; 2017 Feb; 35(6):903-908. PubMed ID: 28081972
[TBL] [Abstract][Full Text] [Related]
17. Rituximab-treated patients have a poor response to influenza vaccination.
Eisenberg RA; Jawad AF; Boyer J; Maurer K; McDonald K; Prak ET; Sullivan KE
J Clin Immunol; 2013 Feb; 33(2):388-96. PubMed ID: 23064976
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus in bone marrow of rheumatoid arthritis patients predicts response to rituximab treatment.
Magnusson M; Brisslert M; Zendjanchi K; Lindh M; Bokarewa MI
Rheumatology (Oxford); 2010 Oct; 49(10):1911-9. PubMed ID: 20547657
[TBL] [Abstract][Full Text] [Related]
19. Which subgroup of patients with rheumatoid arthritis benefits from switching to rituximab versus alternative anti-tumour necrosis factor (TNF) agents after previous failure of an anti-TNF agent?
Finckh A; Ciurea A; Brulhart L; Möller B; Walker UA; Courvoisier D; Kyburz D; Dudler J; Gabay C;
Ann Rheum Dis; 2010 Feb; 69(2):387-93. PubMed ID: 19416802
[TBL] [Abstract][Full Text] [Related]
20. The effect of tumor necrosis factor blockade on the response to pneumococcal vaccination in patients with rheumatoid arthritis and ankylosing spondylitis.
Elkayam O; Caspi D; Reitblatt T; Charboneau D; Rubins JB
Semin Arthritis Rheum; 2004 Feb; 33(4):283-8. PubMed ID: 14978666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
